Publicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (16)

2022

  1. Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting

    Reumatologia Clinica, Vol. 18, Núm. 10, pp. 567-573

  2. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis

    Reumatologia Clinica, Vol. 18, Núm. 1, pp. 33-41

2021

  1. Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up

    Rheumatology (Oxford, England), Vol. 60, Núm. 6, pp. 2906-2915

  2. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study

    European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382

2020

  1. Efficacy and safety of glucocorticoids in rheumatoid arthritis: Systematic literature review

    Reumatologia Clinica, Vol. 16, Núm. 3, pp. 222-228

2019

  1. Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project

    Clinical and experimental rheumatology, Vol. 37, Núm. 5, pp. 731-739

2017

  1. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

  2. Recommendations by the Spanish Society of Rheumatology for the management of patients diagnosed with rheumatoid arthritis who cannot be treated with methotrexate

    Reumatologia Clinica, Vol. 13, Núm. 3, pp. 127-138

2015

  1. Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide

    Reumatologia Clinica, Vol. 11, Núm. 5, pp. 279-294

  2. Effects of an occupational therapy intervention in chronic pain perception and quality of life of patients with rheumatoid arthritis

    Revista de la Sociedad Espanola del Dolor, Vol. 22, Núm. 3, pp. 95-101

2014

  1. PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis

    Pharmacogenomics, Vol. 15, Núm. 14, pp. 1763-1769

2011

  1. Consenso SER sobre la gestión de riesgo del tratamiento con terapias biológicas en pacientes con enfermedades reumáticas

    Reumatologia Clinica, Vol. 7, Núm. 5, pp. 284-298

2010

  1. Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis

    Reumatologia Clinica, Vol. 6, Núm. 1, pp. 23-36

2007

  1. Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas (BIOBADASER): Informe de la situación, 26 de enero de 2006

    Reumatologia Clinica, Vol. 3, Núm. 1, pp. 4-20

2005

  1. El dolor en las consultas de Reumatología españolas: Estudio epidemiológio EPIDOR

    Revista Clinica Espanola, Vol. 205, Núm. 4, pp. 157-163

1989

  1. ARTROPATIA OCRONOTICA

    Revista Espanola de Reumatologia